Literature DB >> 15236761

Chronic exposure to morphine produces a marked cardioprotective phenotype in aged mouse hearts.

Jason N Peart1, Garrett J Gross.   

Abstract

Aging is often associated with decreased myocardial ischemic tolerance. We recently reported that chronic preconditioning produced by continuous exposure to morphine affords a profound cardioprotective phenotype in young mice. In this study, we determined if chronic exposure to morphine retained its ability to precondition the myocardium in the young or aged heart. Young (10-14 weeks) or aged (24-26 months) C57/BL6 mice were untreated, administered morphine acutely (30 microM), or implanted with a morphine pellet (75 mg) for 5 days prior to heart isolation and perfusion. Following equilibration, perfused hearts were subjected to 25 min ischemia and 45 min reperfusion. Untreated hearts from both young and aged mice displayed marked contractile dysfunction and LDH release following reperfusion. Acute infusion of morphine improved recovery of end-diastolic pressure and developed pressure in young (P < 0.05 vs. untreated) but not senescent hearts. Hearts from mice exposed to morphine for 5 days displayed a further improvement in post-ischemic contractile function (P < 0.05 vs. acute treatment), and a marked reduction in post-ischemic LDH efflux (P < 0.05 vs. untreated) in both young and senescent hearts. These data demonstrate that aged hearts maintain the ability to be preconditioned by chronic exposure to morphine in the absence of acute protection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15236761     DOI: 10.1016/j.exger.2004.03.038

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  14 in total

Review 1.  Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.

Authors:  Louise E See Hoe; Lauren T May; John P Headrick; Jason N Peart
Journal:  Br J Pharmacol       Date:  2016-09-09       Impact factor: 8.739

2.  Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy.

Authors:  Andrew J Boyle; Henry Shih; Joy Hwang; Jianqin Ye; Brian Lee; Yan Zhang; David Kwon; Kristine Jun; Daiwei Zheng; Rich Sievers; Franca Angeli; Yerem Yeghiazarians; Randall Lee
Journal:  Exp Gerontol       Date:  2011-03-03       Impact factor: 4.032

3.  Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection.

Authors:  Jason N Peart; Eric R Gross; John P Headrick; Garretta J Gross
Journal:  J Mol Cell Cardiol       Date:  2007-02-28       Impact factor: 5.000

Review 4.  Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart.

Authors:  John P Headrick; Louise E See Hoe; Eugene F Du Toit; Jason N Peart
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

5.  In vitro platelet responsiveness to adenosine-mediated "preconditioning" is age-dependent.

Authors:  Karin Przyklenk; Peter Whittaker
Journal:  J Thromb Thrombolysis       Date:  2005-02       Impact factor: 2.300

Review 6.  Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.

Authors:  Karin Przyklenk
Journal:  Drugs Aging       Date:  2011-05-01       Impact factor: 3.923

7.  Sustained ligand-activated preconditioning via δ-opioid receptors.

Authors:  Jason N Peart; Louise E See Hoe; Garrett J Gross; John P Headrick
Journal:  J Pharmacol Exp Ther       Date:  2010-10-14       Impact factor: 4.030

8.  Chronic β1-adrenoceptor blockade impairs ischaemic tolerance and preconditioning in murine myocardium.

Authors:  Louise E See Hoe; Jan M Schilling; Anna R Busija; Kristofer J Haushalter; Victoria Ozberk; Malik M Keshwani; David M Roth; Eugene Du Toit; John P Headrick; Hemal H Patel; Jason N Peart
Journal:  Eur J Pharmacol       Date:  2016-06-30       Impact factor: 4.432

Review 9.  Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists.

Authors:  Leonid N Maslov; Igor Khaliulin; Peter R Oeltgen; Natalia V Naryzhnaya; Jian-Ming Pei; Stephen A Brown; Yury B Lishmanov; James M Downey
Journal:  Med Res Rev       Date:  2016-05-16       Impact factor: 12.944

10.  Cardiovascular effect of nifedipine in morphine dependent rats: hemodynamic, histopathological, and biochemical evidence.

Authors:  Siyavash Joukar; Mohammad Sheibani; Farzin Joukar
Journal:  Croat Med J       Date:  2012-08       Impact factor: 1.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.